Elopak reported its first quarter with revenue above EUR300m, translating to EBITDA of EUR45m, 3% above our estimate and 1% above consensus. Despite a strong top line, margins contracted 2.6%-points QOQ due to pre-production costs related to its new facility in Little Rock and continued imports from JVs and Europe. We have adjusted our 2026–2027e EPS by 2–1% and reiterate our HOLD, but have increased our target price to NOK44 (40), mainly due to lower tariff concerns and multiples expansion amon...
We estimate Q1 EBITDA of EUR44m, down 6% YOY and 2% below consensus. With EMEA still seeing weak consumer sentiment, we expect a 3% decline in divisional revenue, partly offset by pent-up machine sales. Q1 is set to be the last quarter without commercial support from Little Rock; we expect a flat trend QOQ on continued production constraints. We have lowered our 2026–2027e EPS by 2–1%. We reiterate our HOLD, but have cut our target price to NOK40 (44).
Q4 adj. EBITDA was EUR41m, in line with consensus, while adj. EPS of EUR0.04 missed our EUR0.05 estimate and consensus of EUR0.06, due to a high one-off tax cost. In EMEA, adj. EBITDA of EUR31m missed our forecast, while the Americas kept its momentum with adj. EBITDA of EUR19m, above our estimate. We have reduced our 2025–2026e EPS by 1–3%. We reiterate our HOLD, but have cut our target price to NOK44 (45).
We expect Q4 EBITDA of EUR43m, in line with consensus, but slightly down from previous quarters on continued consumer downtrading and a lack of relief from Americas, which is running at full capacity. We have made minor cuts to our 2025–2026e EPS by c0-2% on potential hits to Canada- and Mexico-to-US exports, higher wood prices affecting packaging-board negotiations, and sticky down-trading. We reiterate our HOLD and target price of NOK45.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.